Trajectories of social withdrawal and cognitive decline in the schizophrenia prodrome

Clinical Schizophrenia and Related Psychoses

Volumn 4, Issue 4, 2011, Pages 229-238

  Cullen, Kathryn ^a,b   Guimaraes, Angela ^a   Wozniak, Jeffrey ^a   Anjum, Afshan ^a   Schulz, S Charles ^a   White, Tonya ^a,b,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Child and adolescent psychiatry; Cognitive decline; Negative symptoms; Prodrome; Schizophrenia; Social withdrawal

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; ILLNESS TRAJECTORY; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; ONSET AGE; PSYCHOSOCIAL WITHDRAWAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIFORM DISORDER; SCHOOL CHILD;

ADOLESCENT; AGE OF ONSET; CHILD; COGNITION DISORDERS; COMORBIDITY; FEMALE; HUMANS; MALE; NETHERLANDS; PERSONALITY DEVELOPMENT; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ADJUSTMENT; YOUNG ADULT;

EID: 78650654929     PISSN: 19351232     EISSN: None     Source Type: Journal    
DOI: 10.3371/CSRP.4.4.3     Document Type: Article

References (68)

1. Carpenter WT Jr, Arango C, Buchanan RW, Kirkpatrick B. Deficit psychopathology and a paradigm shift in schizophrenia research. Biol Psychiatry 1999;46(3):352-360.
2. Binder J, Albus M, Hubmann W, Scherer J, Sobizack N, Franz U, et al. Neuropsychological impairment and psychopathology in first-episode schizophrenic patients related to the early course of illness. Eur Arch Psychiatry Clin Neurosci 1998;248(2):70-77.
3. Rabe-Jablonska J, Kotlicka-Antczak M, Gmitrowticz A. [Clinical picture and duration of prodromal period of schizophrenia in adolescents.] Psychiatr Pol 1999;33(5):715-725. Polish.
4. Bunk D, Eggers C, Klapal M. Symptom dimensions in the course of childhood-onset schizophrenia. Eur Child Adolesc Psychiatry 1999;8 Suppl 1:I29-35.
5. Muratori F, Salvadori F, D'Arcangelo G, Viglione V, Picchi L. Childhood psychopathological antecedents in early onset schizophrenia. Eur Psychiatry 2005;20(4):309-314.
6. Done DJ, Crow TJ, Johnstone EC, Sacker A. Childhood antecedents of schizophrenia and affective illness: Social adjustment at ages 7 and 11. BMJ 1994;309(6956):699-703.
7. Cannon M, Jones P, Gilvarry C, Rifkin L, McKenzie K, Foerster A, et al. Premorbid social functioning in schizophrenia and bipolar disorder: Similarities and differences. Am J Psychiatry 1997;154(11):1544-1550.
8. Fuller R, Nopoulos P, Arndt S, O'Leary D, Ho BC, Andreasen NC. Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance. Am J Psychiatry 2002;159(7):1183-1189.
9. Gunnell D, Harrison G, Rasmussen F, Fouskakis D, Tynelius P. Associations between premorbid intellectual performance, early-life exposures and early-onset schizophrenia. Cohort study. Br J Psychiatry 2002;181:298-305.
10. Eggers C, Bunk D. The long-term course of childhood-onset schizophrenia: A 42-year followup. Schizophr Bull 1997;23(1):105-117.
11. Werry JS, McClellan JM, Chard L. Childhood and adolescent schizophrenic, bipolar, and schizoaffective disorders: A clinical and outcome study. J Am Acad Child Adolesc Psychiatry 1991;30(3):457-465.
12. Rund BR, Melle I, Friis S, Larsen TK, Midboe LJ, Opjordsmoen S, et al. Neurocognitive dysfunction in first-episode psychosis: Correlates with symptoms, premorbid adjustment, and duration of untreated psychosis. Am J Psychiatry 2004;161(3):466-472.
13. Hollis C. Developmental precursors of child- and adolescent-onset schizophrenia and affective psychoses: Diagnostic specificity and continuity with symptom dimensions. Br J Psychiatry 2003;182:37-44.
14. Norman RM, Malla AK, Manchanda R, Townsend L. Premorbid adjustment in first episode schizophrenia and schizoaffective disorders: A comparison of social and academic domains. Acta Psychiatr Scand 2005;112(1):30-39.
15. Baum KM, Walker EF. Childhood behavioral precursors of adult symptom dimensions in schizophrenia. Schizophr Res 1995;16(2):111-120.
16. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997;36(7):980-988.
17. Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS). Iowa City (IA): The University of Iowa; 1983.
18. Andreasen NC. The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City (IA): The University of Iowa; 1984.
19. Galynker II, Dutta E, Vilkas N, Ongseng F, Finestone H, Gallagher R, et al. Hypofrontality and negative symptoms in patients with dementia of Alzheimer type. Neuropsychiatry Neuropsychol Behav Neurol 2000;13(1):53-59.
20. Brebion G, Amador X, Smith MJ, Malaspina D, Sharif Z, Gorman JM. Opposite links of positive and negative symptomatology with memory errors in schizophrenia. Psychiatry Res 1999;88(1):15-24.
21. Oades RD, Ropcke B, Henning U, Klimke A. Neuropsychological measures of attention and memory function in schizophrenia: Relationships with symptom dimensions and serum monoamine activity. Behav Brain Funct 2005;1:14.
22. Debruille JB, Kumar N, Saheb D, Chintoh A, Gharghi D, Lionnet C, et al. Delusions and processing of discrepant information: An event-related brain potential study. Schizophr Res 2007;89(1-3):261-277.
23. Ho BC, Alicata D, Mola C, Andreasen NC. Hippocampus volume and treatment delays in first-episode schizophrenia. Am J Psychiatry 2005;162(8):1527-1529.
24. Goldberg TE, Burdick KE, McCormack J, Napolitano B, Patel RC, Sevy SM, et al. Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first episode schizophrenia. Schizophr Res 2009;107(2-3):262-266.
25. Kirkpatrick B, Buchanan RW, Breier A, Carpenter WT Jr. Case identification and stability of the deficit syndrome of schizophrenia. Psychiatry Res 1993;47(1):47-56.
26. Subotnik KL, Nuechterlein KH, Ventura J, Green MF, Hwang SS. Prediction of the deficit syndrome from initial deficit symptoms in the early course of schizophrenia. Psychiatry Res 1998;80(1):53-59.
27. McGee R, Williams S, Poulton R. Hallucinations in nonpsychotic children. J Am Acad Child Adolesc Psychiatry 2000;39(1):12-13.
28. Schreier HA. Hallucinations in nonpsychotic children: More common than we think? J Am Acad Child Adolesc Psychiatry 1999;38(5):623-625.
29. Sosland MD, Edelsohn GA. Hallucinations in children and adolescents. Curr Psychiatry Rep 2005;7(3):180-188.
30. DeMarce JM, Burden JL, Lash SJ, Stephens RS, Grambow SC. Convergent validity of the Timeline Followback for persons with comorbid psychiatric disorders engaged in residential substance use treatment. Addict Behav 2007;32(8):1582-1592.
31. Carey MP, Carey KB, Maisto SA, Gordon CM, Weinhardt LS. Assessing sexual risk behaviour with the Timeline Followback (TLFB) approach: Continued development and psychometric evaluation with psychiatric outpatients. Int J STD AIDS 2001;12(6):365-375.
32. Dillon FR, Turner CW, Robbins MS, Szapocznik J. Concordance among biological, interview, and self-report measures of drug use among African American and Hispanic adolescents referred for drug abuse treatment. Psychol Addict Behav 2005;19(4):404-413.
33. Carey KB, Carey MP, Maisto SA, Henson JM. Temporal stability of the timeline followback interview for alcohol and drug use with psychiatric outpatients. J Stud Alcohol 2004;65(6):774-781.
34. Donohue B, Hill HH, Azrin NH, Cross C, Strada MJ. Psychometric support for contemporaneous and retrospective youth and parent reports of adolescent marijuana use frequency in an adolescent outpatient treatment population. Addict Behav 2007;32(9):1787-1797.
35. Donohue B, Azrin NH, Strada MJ, Silver NC, Teichner G, Murphy H. Psychometric evaluation of self- and collateral timeline follow-back reports of drug and alcohol use in a sample of drug-abusing and conduct-disordered adolescents and their parents. Psychol Addict Behav 2004;18(2):184-189.
36. van Mastrigt S, Addington J. Assessment of premorbid function in first-episode schizophrenia: Modifications to the Premorbid Adjustment Scale. J Psychiatry Neurosci 2002;27(2):92-101.
37. Cannon-Spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 1982;8(3):470-484.
38. Brill N, Reichenberg A, Weiser M, Rabinowitz J. Validity of the premorbid adjustment scale. Schizophr Bull 2008;34(5):981-983.
39. Bleuler E. Demential Praecox of the Group of Schizophrenias. New York: International Universities Press; 1950.
40. Nicolson R, Lenane M, Singaracharlu S, Malaspina D, Giedd JN, Hamburger SD, et al. Premorbid speech and language impairments in childhood-onset schizophrenia: Association with risk factors. Am J Psychiatry 2000;157(5):794-800.
41. Asarnow JR, Ben-Meir S. Children with schizophrenia spectrum and depressive disorders: A comparative study of premorbid adjustment, onset pattern and severity of impairment. J Child Psychol Psychiatry 1988;29(4):477-488.
42. Kravariti E, Morris RG, Rabe-Hesketh S, Murray RM, Frangou S. The Maudsley early onset schizophrenia study: Cognitive function in adolescents with recent onset schizophrenia. Schizophr Res 2003;61(2-3):137-148.
43. Kenny JT, Friedman L, Findling RL, Swales TP, Strauss ME, Jesberger JA, et al. Cognitive impairment in adolescents with schizophrenia. Am J Psychiatry 1997;154(11):1613-1615.
44. Ang YG, Tan HY. Academic deterioration prior to first episode schizophrenia in young Singaporean males. Psychiatry Res 2004;121(3):303-307.
45. Byrne M, Hodges A, Grant E, Owens DC, Johnstone EC. Neuropsychological assessment of young people at high genetic risk for developing schizophrenia compared with controls: Preliminary findings of the Edinburgh High Risk Study (EHRS). Psychol Med 1999;29(5):1161-1173.
46. Caspi A, Reichenberg A, Weiser M, Rabinowitz J, Kaplan Z, Knobler H, et al. Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode. Schizophr Res 2003;65(2-3):87-94.
47. Lawrie SM, Byrne M, Miller P, Hodges A, Clafferty RA, Cunningham Owens DG, et al. Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia. Br J Psychiatry 2001;178:524-530. (Pubitemid 32531745)
48. Brewer WJ, Francey SM, Wood SJ, Jackson HJ, Pantelis C, Phillips LJ, et al. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am J Psychiatry 2005;162(1):71-78.
49. Brewer WJ, Wood SJ, Phillips LJ, Francey SM, Pantelis C, Yung AR, et al. Generalized and specific cognitive performance in clinical high-risk cohorts: A review highlighting potential vulnerability markers for psychosis. Schizophr Bull 2006;32(3):538-555.
50. Wood SJ, Yucel M, Yung AR, Berger GE, Velakoulis D, Pantelis C. The transition to psychosis: Risk factors and brain changes. Epidemiol Psichiatr Soc 2004;13(3):137-140.
51. Wood SJ, Brewer WJ, Koutsouradis P, Phillips LJ, Francey SM, Proffitt TM, et al. Cognitive decline following psychosis onset: Data from the PACE clinic. Br J Psychiatry Suppl 2007;51:s52-57.
52. Craig TK, Garety P, Power P, Rahaman N, Colbert S, Fornells-Ambrojo M, et al. The Lambeth Early Onset (LEO) Team: Randomised controlled trial of the effectiveness of specialised care for early psychosis. BMJ 2004;329(7474):1067.
53. Schaffner KF, McGorry PD. Preventing severe mental illnesses-new prospects and ethical challenges. Schizophr Res 2001;51(1):3-15.
54. Jorgensen P, Nordentoft M, Abel MB, Gouliaev G, Jeppesen P, Kassow P. Early detection and assertive community treatment of young psychotics: The Opus Study Rationale and design of the trial. Soc Psychiatry Psychiatr Epidemiol 2000;35(7):283-287.
55. Salokangas RK, McGlashan TH. Early detection and intervention of psychosis. A review. Nord J Psychiatry 2008;62(2):92-105.
56. Owens DG, Miller P, Lawrie SM, Johnstone EC. Pathogenesis of schizophrenia: A psychopathological perspective. Br J Psychiatry 2005;186:386-393.
57. McGlashan TH, Addington J, Cannon T, Heinimaa M, McGorry P, O'Brien M, et al. Recruitment and treatment practices for help-seeking "prodromal" patients. Schizophr Bull 2007;33(3):715-726.
58. Bechdolf A, Veith V, Schwarzer D, Schormann M, Stamm E, Janssen B, et al. Cognitive-behavioral therapy in the pre-psychotic phase: An exploratory study. Psychiatry Res 2005;136(2-3):251-255.
59. McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 2002;59(10):921-928.
60. Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: Randomised controlled trial. Br J Psychiatry 2004;185:291-297.
61. Bellino S, Rocca P, Patria L, Marchiaro L, Rasetti R, Di Lorenzo R, et al. Relationships of age at onset with clinical features and cognitive functions in a sample of schizophrenia patients. J Clin Psychiatry 2004;65(7):908-914.
62. Schultz SK, Ho BC, Andreasen NC. Clinical features characterizing young-onset and intermediate-onset schizophrenia. J Neuropsychiatry Clin Neurosci 2000;12(4):502-505.
63. Jafri MJ, Pearlson GD, Stevens M, Calhoun VD. A method for functional network connectivity among spatially independent resting-state components in schizophrenia. Neuroimage 2008;39(4):1666-1681.
64. Begre S, Koenig T. Cerebral disconnectivity: An early event in schizophrenia. Neuroscientist 2008;14(1):19-45.
65. Andreasen NC, Paradiso S, O'Leary DS. "Cognitive dysmetria" as an integrative theory of schizophrenia: A dysfunction in cortical-subcortical- cerebellar circuitry? Schizophr Bull 1998;24(2):203-218.
66. Cheung V, Cheung C, McAlonan GM, Deng Y, Wong JG, Yip L, et al. A diffusion tensor imaging study of structural dysconnectivity in never-medicated, first-episode schizophrenia. Psychol Med 2008;38(6):877-885.
67. Woods SW, Breier A, Zipursky RB, Perkins DO, Addington J, Miller TJ, et al. Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biol Psychiatry 2003;54(4):453-464.
68. Addington J, Cadenhead KS, Cannon TD, Cornblatt B, McGlashan TH, Perkins DO, et al. North American Prodrome Longitudinal Study: A collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull 2007;33(3):665-672.